Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -Q1 group results

Aug 6 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             8.65                8.85             36.00    
                 (-2.2 pct)          (+39.2 pct)      (+0.4 pct)  
  Operating         2.25                1.54              6.20    
                 (+45.8 pct)        (+487.8 pct)      (+13.5 pct) 
  Recurring         2.20                1.56              6.45    
                 (+41.1 pct)        (+442.0 pct)      (+13.9 pct) 
  Net               1.59                1.03              4.25    
                 (+54.2 pct)                          (+16.2 pct) 
  EPS             13.22 yen           8.57 yen         35.29 yen  
  Ann Div                             7.00 yen         8.00 yen   
  -Q2 div                                NIL              NIL     
  -Q4 div                             7.00 yen         8.00 yen   
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news